更正：韩国高级别前列腺癌风险计算器的开发与外部验证：在亚洲队列中与两种西方风险计算器的比较。
Correction: Development and External Validation of the Korean Prostate Cancer Risk Calculator for High-Grade Prostate Cancer: Comparison with Two Western Risk Calculators in an Asian Cohort.
出版信息
PLoS One. 2017 Apr 6;12(4):e0175606. doi: 10.1371/journal.pone.0175606. eCollection 2017.
Abstract
[This corrects the article DOI: 10.1371/journal.pone.0168917.].
摘要
[本文更正了文章的数字对象标识符：10.1371/journal.pone.0168917。]
相似文献
1
Correction: Development and External Validation of the Korean Prostate Cancer Risk Calculator for High-Grade Prostate Cancer: Comparison with Two Western Risk Calculators in an Asian Cohort.更正：韩国高级别前列腺癌风险计算器的开发与外部验证：在亚洲队列中与两种西方风险计算器的比较。
PLoS One. 2017 Apr 6;12(4):e0175606. doi: 10.1371/journal.pone.0175606. eCollection 2017.
2
Predicting prostate cancer: analysing the clinical efficacy of prostate cancer risk calculators in a referral population.预测前列腺癌：分析转诊人群中前列腺癌风险计算器的临床疗效。
Ir J Med Sci. 2015 Sep;184(3):701-6. doi: 10.1007/s11845-015-1291-8. Epub 2015 Apr 7.
4
Performance of prostate cancer prevention trial risk calculator in a contemporary cohort screened for prostate cancer and diagnosed by extended prostate biopsy.在经前列腺癌筛查和扩展前列腺活检诊断的当代队列中，前列腺癌预防试验风险计算器的表现。
J Urol. 2010 Feb;183(2):529-33. doi: 10.1016/j.juro.2009.10.007. Epub 2009 Dec 14.
5
Evaluation of Prostate Cancer Risk Calculators for Shared Decision Making Across Diverse Urology Practices in Michigan.密歇根州不同泌尿外科实践中用于共同决策的前列腺癌风险计算器评估
Urology. 2017 Jun;104:137-142. doi: 10.1016/j.urology.2017.01.039. Epub 2017 Feb 22.
6
European Randomised Study of Screening for Prostate Cancer (ERSPC) risk calculators significantly outperform the Prostate Cancer Prevention Trial (PCPT) 2.0 in the prediction of prostate cancer: a multi-institutional study.欧洲前列腺癌筛查随机研究（ERSPC）风险计算器在预测前列腺癌方面显著优于前列腺癌预防试验（PCPT）2.0：一项多机构研究。
BJU Int. 2016 Nov;118(5):706-713. doi: 10.1111/bju.13437. Epub 2016 Feb 29.
7
External validation of Chun, PCPT, ERSPC, Kawakami, and Karakiewicz nomograms in the prediction of prostate cancer: A single center cohort-study.Chun、PCPT、ERSPC、Kawakami和Karakiewicz列线图在预测前列腺癌方面的外部验证：一项单中心队列研究。
Urol Oncol. 2018 Aug;36(8):364.e1-364.e7. doi: 10.1016/j.urolonc.2018.05.010. Epub 2018 Jun 5.
8
Correction: Validation of Novel Biomarkers for Prostate Cancer Progression by the Combination of Bioinformatics, Clinical and Functional Studies.更正：通过生物信息学、临床和功能研究相结合对前列腺癌进展的新型生物标志物进行验证
PLoS One. 2016 Jun 21;11(6):e0158255. doi: 10.1371/journal.pone.0158255. eCollection 2016.
9
Correction: Challenges of developing a cardiovascular risk calculator for patients with rheumatoid arthritis.更正：为类风湿关节炎患者开发心血管风险计算器的挑战。
PLoS One. 2017 Apr 7;12(4):e0175605. doi: 10.1371/journal.pone.0175605. eCollection 2017.
10
Correction: Predicting Hospitalised Paediatric Pneumonia Mortality Risk: An External Validation of RISC and mRISC, and Local Tool Development (RISC-Malawi) from Malawi.更正：预测住院小儿肺炎死亡风险：RISC和mRISC的外部验证以及马拉维的本地工具开发（RISC-马拉维）
PLoS One. 2018 Feb 22;13(2):e0193557. doi: 10.1371/journal.pone.0193557. eCollection 2018.
本文引用的文献
1
Development and External Validation of the Korean Prostate Cancer Risk Calculator for High-Grade Prostate Cancer: Comparison with Two Western Risk Calculators in an Asian Cohort.韩国高级别前列腺癌风险计算器的开发与外部验证：在亚洲队列中与两种西方风险计算器的比较。
PLoS One. 2017 Jan 3;12(1):e0168917. doi: 10.1371/journal.pone.0168917. eCollection 2017.
Zotero 插件